Placeholder Banner

Senate Confirms Dr. Hahn to Lead the Food and Drug Administration

December 12, 2019
Media Contact
Author-Profile-Andrew-Segerman

Former Congressman Jim Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the U.S. Senate confirmed Dr. Stephen Hahn to serve as the next commissioner of the Food and Drug Administration:

“The Food and Drug Administration plays a critical role in helping to ensure patients and consumers have access to the innovative medicines our scientists and researchers discover, as well as to the next wave of food-related biotechnology innovation. We congratulate Dr. Hahn on his confirmation, and we look forward to working with him and the entire FDA team to ensure the American people continue to benefit from the power and promise of biotechnology.”

###

Discover More
New focus on justice through equity in diverse clinical trials, STEM education and expanding entrepreneurship to undeserved communities will drive nation’s largest life science advocacy organization The Biotechnology Innovation Organization (BIO)…
Says biopharma researchers and scientists stand ready to support real solutions that will address patient drug costs, continue lifesaving science Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO),…
In response to attacks on Dr. Anthony Fauci’s credibility and character, BIO President and CEO Dr. Michelle McMurry-Heath issued the following statement: “As this global pandemic continues to wreak havoc, we must stand behind the scientists and…